Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Market Cap	43.75M
Revenue (ttm)	81.16M
Net Income (ttm)	3.61M
Shares Out	35.00M
EPS (ttm)	0.10
PE Ratio	12.12
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	975
Average Volume	32,416
Open	1.250
Previous Close	1.260
Day's Range	1.250 - 1.250
52-Week Range	1.210 - 1.420
Beta	0.26
RSI	45.78
Earnings Date	Feb 12, 2025

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,067
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2024, ASE:DADI's revenue was 81.16 million, an increase of 8.39% compared to the previous year's 74.88 million. Earnings were 3.61 million, an increase of 14.16%.